Literature DB >> 10363861

Evans syndrome: successful management with multi-agent treatment including intermediate-dose intravenous cyclophosphamide.

N Gombakis, M Trahana, M Athanassiou, F Kanakoudi-Tsakalidou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10363861     DOI： 10.1097/00043426-199905000-00016

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  4 in total

1.  Clinical applications of immunoglobulin: update.

Authors:  Marcia Cristina Zago Novaretti; Carla Luana Dinardo
Journal:  Rev Bras Hematol Hemoter       Date:  2011

2.  Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome.

Authors:  Piero Farruggia; Alessandra Macaluso; Serena Tropia; Selene Genova; Olivia Paolicchi; Floriana Di Marco; Paolo D'Angelo
Journal:  Pediatr Rep       Date:  2011-06-16

3.  Anti-CD20 Treatment of Autoimmune Hemolytic Anemia Refractory to Corticosteroids and Azathioprine: A Pediatric Case Report and Mini Review.

Authors:  Alexandros Makis; Zoi Kanta; Dimitrios Kalogeropoulos; Nikoloaos Chaliasos
Journal:  Case Rep Hematol       Date:  2018-08-26

Review 4.  Evans syndrome: clinical perspectives, biological insights and treatment modalities.

Authors:  José Carlos Jaime-Pérez; Patrizia Elva Aguilar-Calderón; Lorena Salazar-Cavazos; David Gómez-Almaguer
Journal:  J Blood Med       Date:  2018-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.